BioMarin Announces Appointment of Ian T. Clark to Board of Directors
BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) announced that the company has appointed Ian T. Clark to the company's Board of Directors, effective today, August 1, 2025. https://mma.prnewswire.com/media/534018/BioMarin_Pharmaceutical_Inc_Logo.jpg Mr. Clark served as Chief Executive Officer of Genentech and a member of the company's Board of Directors from 2010 until his retirement in 2016. Under his leadership, Genentech […]